Fujifilm Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
43
About the Report
About the Report
Summary
Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company's product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofinishing, functional materials, graphic systems, recording media, electronic materials and industrial products, and office printers. The company offers its services to individual consumers and business enterprises. Fujifilm conducts its business operations through its subsidiaries across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. The company is headquartered in Tokyo, Japan.
Fujifilm Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 10
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Fujifilm Corp, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Fujifilm to Enter into Partnership with Zhejiang Hisun Pharma, China-Japan Friendship Clinic and National Engineering Research Center 13
Fujifilm and Takeda Pharma Enter into Agreement 14
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 15
EdiGene Enters into Research Agreement with Fujifilm 16
CanBas Enters into Research Agreement with Fujifilm 17
FunPep Enters into Research Agreement with Fujifilm 18
China Resources Pharmaceutical Enters into Agreement with Fujifilm 19
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 20
Bioaster Partners with Fujifilm 21
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 22
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 23
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 24
Licensing Agreements 26
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 26
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 27
Equity Offering 28
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 28
Fujifilm Invests USD0.3 Million in Japan Biomedical 29
Fujifilm Invests USD1.5 Million in Regcell 30
Acquisition 31
Fujifilm Acquires 11.7% Stake in EdiGene 31
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 32
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 33
Fujifilm Corp-Key Competitors 34
Fujifilm Corp-Key Employees 35
Fujifilm Corp-Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 39
Recent Developments 40
Strategy And Business Planning 40
Feb 28, 2017: Expanding Fast-Growing Contract Development and Manufacturing Business for Biopharmaceuticals, FUJIFILM Launches the Bio CDMO Division 40
Legal and Regulatory 41
Aug 01, 2018: US judge finds Fujifilm infringed on Hologic's mammography patents 41
Other Significant Developments 42
Nov 06, 2017: Fujifilm Expands Biopharmaceutical Contract Development and Manufacturing Business, Increasing Monoclonal Antibody Capacity for Process Development and GMP Production at U.S.A. and U.K. Sites 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Figure
List of Figures
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Fujifilm Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Fujifilm Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 10
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Fujifilm to Enter into Partnership with Zhejiang Hisun Pharma, China-Japan Friendship Clinic and National Engineering Research Center 13
Fujifilm and Takeda Pharma Enter into Agreement 14
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 15
EdiGene Enters into Research Agreement with Fujifilm 16
CanBas Enters into Research Agreement with Fujifilm 17
FunPep Enters into Research Agreement with Fujifilm 18
China Resources Pharmaceutical Enters into Agreement with Fujifilm 19
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 20
Bioaster Partners with Fujifilm 21
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 22
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 23
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 24
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 26
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 27
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 28
Fujifilm Invests USD0.3 Million in Japan Biomedical 29
Fujifilm Invests USD1.5 Million in Regcell 30
Fujifilm Acquires 11.7% Stake in EdiGene 31
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 32
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 33
Fujifilm Corp, Key Competitors 34
Fujifilm Corp, Key Employees 35
Fujifilm Corp, Other Locations 36
Fujifilm Corp, Subsidiaries 37
Fujifilm Corp, Joint Venture 39
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.